loader2
Partner With Us NRI

Advanced Enzyme Technologies Ltd share Price Today

Company details

368.05
376.40
265.60
425.15
6M Return 13.44%
1Y Return 35.53%
Mkt Cap.(Cr) 4,176.07
Volume 88,777
Div Yield 0.29%
OI
-
OI Chg %
-
Volume 88,777

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
About The Stock

    Advanced Enzyme Technologies (AET) is a focused, research driven Indian enzymes company with a product basket of 400+ proprietary products developed from 68 indigenous enzymes and probiotics.

    • The business is divided into three segments - 1) human healthcare, 2) animal healthcare and 3) industrial processing business
    • It has nine manufacturing and seven R&D facilities, which consist of three integrated fermentations, recovery & formulation facilities, one extraction and recovery facility and one satellite blending, mixing & formulation facility
Q1FY23

    Margin pressure and elongated recovery at the clients’ end continue to weigh.

    • Revenues were down 12% YoY to ₹ 121 crore
    • EBITDA was at ₹ 31 crore, down 51% YoY with margins at 25.5%

    PAT was at ₹ 18 crore (down 53% YoY)

Click here for full recommendation

Research view on more stocks

Biotechnology company Advanced Enzyme Technologies announced consolidated Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Revenue from Operations: Revenue from operations on consolidated basis increased to Rs 1,578 million in the Q4FY24 from Rs 1,387 million in the Q4FY23, a growth of 14%.
  • Profit: Consolidated EBITDA during Q4FY24 stands at Rs 554 million as compared to Rs 441 million during Q4FY23, an increase of 26%.
  • Profit before tax stands at Rs 397 million during Q4FY24 as against Rs 421 million in Q4FY23, decrease of 6%.
  • Profit after tax de-grew by 7% and stands at Rs 299 million during Q4FY24 as compared to Rs 321 million during the Q4FY23.
  • Margin: EBITDA margin stands at 35%, PBT margin stands at 25% and PAT margin stood at 19% during the quarter.
  • Financial Costs: Financial costs stood at Rs 8 million during Q4FY24 as against Rs 6 million in Q4FY23.
  • Depreciation and Amortization: Depreciation and Amortization charge for the Q4FY24 stood at Rs 93 million as compared to Rs 84 million, the same quarter previous year.
  • Earnings Per Share: Earnings Per Share during Q4FY24 stands at Rs 2.53 as compared to Rs 2.87 in Q4FY23.

FY24 Financial Highlights:

  • Revenue from Operations: Revenue from operations on consolidated basis increased to Rs 6,239 million in the FY24 from Rs 5,406 million in the FY23, reported an increase of 15%.
  • Profit: Consolidated EBITDA during FY24 stands at Rs 2,045 million as compared to Rs 1,546 million during FY23, growth of 31%.
  • Profit before tax stands at Rs 1,879 million during FY24 as against Rs 1,404 million in FY23, an increase of 34%
  • Profit after tax stands at Rs 1,370 million during FY24 as compared to Rs 1,039 million during the FY23, an increase of 32%.
  • Margin: EBITDA margin stands at 33%, PBT margin stands at 30% and PAT margin stands at 22% during the FY24.
  • Financial Costs: Financial costs stood at Rs 29 million during FY24 as against Rs 24 million in FY23.
  • Depreciation and Amortization: Depreciation and Amortization charge for the FY24 is Rs 353 million as compared to Rs 350 million in FY23.
  • Earnings Per Share: Earnings Per Share during FY24 stands at Rs 11.92 as compared to Rs 9.45 in FY23.

Result PDF

View Other Company Results

Advanced Enzyme Technologies Ltd shares SWOT Analysis

Strengths (5)

  • Company with Low Debt
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Book Value per share Improving for last 2 years

Weakness (0)

Data not found

Opportunity (0)

Data not found

Threats (1)

  • Promoter decreasing their shareholding

Resistance and support

R1 377.2
R2 381.0
R3 385.6
Pivot

372.63

S1 368.9
S2 364.3
S3 360.5
EMA SMA
377.8
376.5
370.7
354.4
382.8
371.5
377.0
354.4
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-12-06 357.73 723134 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2023-12-06 358.11 723134 NSE
ADVANCED VITAL ENZYMES PRIVATE LIMITED Bulk Sell 2023-12-06 359.25 618105 NSE
Name Category Shares
Kishor Laxminarayan Rathi PROMOTER 1.31%
Madhusudan Kabra PROMOTER 0.64%
Vasant Rathi PROMOTER 33.14%
Rasika Vasant Rathi PROMOTER 2.38%
Reshma Namita Rathi PROMOTER 2.37%
Rachana Vasant Rathi PROMOTER 2.36%
Prabhavati Vasant Rathi PROMOTER 0.82%

OUR RESEARCH VIEW

Investment recommendation
Call Date
06 Aug 2022
Entry Price 293.00
Target Price 265.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Advanced Enzyme Technologies Ltd Stocks COMPARISON

Financials( in Cr) Advanced Enzyme Technologies Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 373.45 1,464.90 1,479.45 4,392.10 1,052.95
% Change -0.09 -0.08 0.05 3.22 -0.52
Mcap Cr 4,176.07 351,478.58 119,445.91 116,596.64 105,951.41
Revenue TTM Cr 540.64 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 103.87 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 28.96 35.12 28.05 72.85 27.42
1 Year Return 35.53 51.26 54.71 26.29 105.63
ROCE 12.02 16.79 14.76 19.30 16.25
ROE 8.94 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,235.07 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 39,096.78 -22,281.88
LAST 3M 109,317.46 -33,313.91
LAST 6M 173,877.04 36,325.60
LAST 12M 271,641.54 124,224.97
Advanced Enzyme Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates

May 23, 2024 l NSE Announcement

Advanced Enzyme Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates

May 22, 2024 l NSE Announcement

Date Action Type Ratio
May 17, 2024 Dividend 200
Aug 04, 2023 Dividend 50
May 19, 2023 Dividend 200

Advanced Enzyme Technologies Ltd Information

Stock PE (TTM)
28.96
Promoter Holding
43.49%
Book Value
118.4114
ROCE
12.02%
ROE
8.94%
Description
  • Advanced Enzyme Technologies Limited is a manufacturing enzymes sector company having a market capitalization of is 5,100.96 Crores as of 15-May-2021. The company was incorporated in 1945. The company has reported its consolidated quarterly revenue of Rs. 139.09 Cr. at the end of December 2020. The company is found listed on the Bombay Stock Exchange (BSE) with the code 540025 and also listed on National Stock Exchange (NSE) with the symbol ADVENZYMES. Advanced Enzymes is the largest Indian enzyme company engaged in the research and development dedicated to marketing eco-safe solutions to a wide variety of industries like Pharmaceuticals, Baking, Agriculture, Waste Management, Textile, Leather, Distilling, Grain Processing, Juice Processing, etc, developed from over 65 indigenous enzymes & probiotics. As of March 31, 2020, the Company has 6 (six) direct subsidiaries and 5 (five) step-down subsidiaries. Out of which 3 (three) are Indian subsidiaries and 8 (eight) are foreign subsidiaries make a strong presence across 45 countries worldwide. With exports across 6 continents, they provide customized and effective enzyme solutions coupled with the best in technical advice and superior service. 20 patents. The company has granted more than 20 patents, currently having more than 550 employees, more than 25 years of fragmentation experience. The current fragmentation capacity of AETL is 470 m³. To strength, its product, Company spending on R & D as a percentage of turnover is increasing from past 4 years( As per March 2020, R & D cost to total turnover is 4.95%) Advanced Enzyme Technologies Limited (AETL) is having is earning 43% revenue from India and 57% revenue internationally. ATL is having high TTM EPS growth with Low debt. For F.Y 19-20. Annual net profits and Book value per share also increasing for the past 2 years. ATL is a company having zero promoter pledges and Strong cash-generating ability from its core business. As on 31-March 20, AETL is a company having zero promoter pledge and Strong cash-generating ability from core business.

Registered Address

Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi, Thane, Maharashtra, 400604

Tel : 91-22-41703200
Email : sanjay:advancedenzymes.com; info:advancedenzymes.c
Website : http://www.advancedenzymes.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 540025
NSE Code : ADVENZYMES
Book Closure Date (Month) :
BSE Group : B
ISIN : INE837H01020

FAQ’s on Advanced Enzyme Technologies Ltd Shares

You can buy Advanced Enzyme Technologies Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Advanced Enzyme Technologies Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 28, 2024 03:58 PM the closing price of Advanced Enzyme Technologies Ltd was Rs.373.45.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 28, 2024 03:58 PM, the market cap of Advanced Enzyme Technologies Ltd stood at Rs. 4,176.07.

The latest PE ratio of Advanced Enzyme Technologies Ltd as of May 28, 2024 03:58 PM is 28.96

The latest PB ratio of Advanced Enzyme Technologies Ltd as of May 28, 2024 03:58 PM is 0.32

The 52-week high of Advanced Enzyme Technologies Ltd share price is Rs. 425.15 while the 52-week low is Rs. 265.60

According to analyst recommendations, Advanced Enzyme Technologies Ltd Share has a "Buy" rating for the long term.

Download App

Download Our App

Play Store App Store
market app